AU2023265523A1 - Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration - Google Patents

Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration Download PDF

Info

Publication number
AU2023265523A1
AU2023265523A1 AU2023265523A AU2023265523A AU2023265523A1 AU 2023265523 A1 AU2023265523 A1 AU 2023265523A1 AU 2023265523 A AU2023265523 A AU 2023265523A AU 2023265523 A AU2023265523 A AU 2023265523A AU 2023265523 A1 AU2023265523 A1 AU 2023265523A1
Authority
AU
Australia
Prior art keywords
compound
certain embodiments
subject
group
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023265523A
Other languages
English (en)
Inventor
Huey CAI
Lucian DEL PRIORE
Mark Fields
Denton HOYER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU2023265523A1 publication Critical patent/AU2023265523A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2023265523A 2022-05-04 2023-05-04 Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration Pending AU2023265523A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263338264P 2022-05-04 2022-05-04
US63/338,264 2022-05-04
US202263411405P 2022-09-29 2022-09-29
US63/411,405 2022-09-29
PCT/US2023/020978 WO2023215465A1 (en) 2022-05-04 2023-05-04 Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration

Publications (1)

Publication Number Publication Date
AU2023265523A1 true AU2023265523A1 (en) 2024-11-21

Family

ID=88647025

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023265523A Pending AU2023265523A1 (en) 2022-05-04 2023-05-04 Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration

Country Status (7)

Country Link
US (1) US20250288588A1 (cg-RX-API-DMAC7.html)
EP (1) EP4519268A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025516315A (cg-RX-API-DMAC7.html)
CN (1) CN119487033A (cg-RX-API-DMAC7.html)
AU (1) AU2023265523A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251997A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023215465A1 (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
EP4519268A1 (en) 2025-03-12
JP2025516315A (ja) 2025-05-27
WO2023215465A1 (en) 2023-11-09
US20250288588A1 (en) 2025-09-18
CA3251997A1 (en) 2023-11-09
CN119487033A (zh) 2025-02-18

Similar Documents

Publication Publication Date Title
JP6602802B2 (ja) Ssaoの置換3−ハロアリルアミン阻害剤およびその使用
US7087645B2 (en) Compounds and methods for treating transplant rejection
US10526297B2 (en) Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
US11858910B2 (en) Pyridinylmethylenepiperidine derivatives and uses thereof
US20030134802A1 (en) Novel effectors of dipepetidyl peptidase IV
IL126836A (en) Beta-inhibitor of protein kinase C beta-use for use as a drug for the treatment of eye diseases
CN115768419A (zh) 用于色满卡林前药治疗的改进方法和组合物
CA3145738A1 (en) Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof
US20230017597A1 (en) 8-substituted styryl xanthine derivatives and uses thereof
US20250288588A1 (en) Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration
US20250222115A1 (en) Drug Conjugates of Sugar Derivatives and Uses Thereof as Senolytic Agents
US20150197536A1 (en) Compounds reducing the production of sorbitol in the eye and methods of using the same
EP4229058B1 (en) Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof
WO2025199211A1 (en) Imidazopyridines and imidazopyrimidines, and methods of using same
US20210206773A1 (en) Drug for treating disorders of corneal epithelium
KR101799429B1 (ko) 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물
KR101896398B1 (ko) 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물
US12310970B2 (en) Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerations
US9856230B2 (en) Enzyme inhibitors
JP2005529160A (ja) 糖尿病及び糖尿病−関連障害の処置のための化合物及び組成物
HK40093954A (en) Substituted 4‑([1,2,4]triazolo[1,5‑a]pyridin‑6‑yl)thiophene‑2‑carboxamide derivatives and use thereof
CN118591529A (zh) 氘代rock抑制剂、药物组合物和治疗应用
WO2024044813A1 (en) Novel selective inhibitors of lysyl oxidases
CN121270631A (zh) 含一氧化氮供体的化合物
CN108864033A (zh) 苯基取代的酰肼衍生物及其用途